These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6688151

  • 1. Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas.
    Sternberg CN, Magill GB, Sordillo PP, Cheng E, Currie VE.
    Am J Clin Oncol; 1983 Aug; 6(4):459-62. PubMed ID: 6688151
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
    Schneider RJ, Woodcock TM, Yagoda A.
    Cancer Treat Rep; 1980 Jan; 64(1):183-5. PubMed ID: 6892892
    [No Abstract] [Full Text] [Related]

  • 6. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
    Casper ES, Gralla RJ, Kelsen DP, Natale RB, Sordillo P, Houghton A.
    Cancer Treat Rep; 1980 Jan; 64(2-3):345-7. PubMed ID: 6893294
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
    Carroll DS, Kemeny N, Lynch G, Wookcock T.
    Cancer Treat Rep; 1980 Jan; 64(10-11):1149-50. PubMed ID: 6893951
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC, Zwelling LA, Gormley P, Young RC.
    Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma.
    Dombernowsky P, Siegenthaler P, Somers R, Hansen HH.
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):71-4. PubMed ID: 6896306
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
    Ratanatharathorn V, Drelichman A, Sexon-Porte M, Al-Sarraf M.
    Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase II trial of (m-AMSA) 4'-9-(acridinylamino)-methanesulfon-m-aniside in primary liver cancer.
    Cheng E, Lightdale C, Young C, Yagoda A, Fortner J, Golbey R.
    Am J Clin Oncol; 1983 Apr; 6(2):211-3. PubMed ID: 6299095
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia.
    Kahn SB, Sklaroff R, Lebedda J, Conroy JF, Bulova S, Brodsky I.
    Am J Clin Oncol; 1983 Aug; 6(4):493-502. PubMed ID: 6191561
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of AMSA in children with acute leukemia. A Pediatric Oncology Group study.
    Krischer J, Land VJ, Civin CI, Ragab AH, Mahoney DH, Frankel LS.
    Cancer; 1984 Jul 15; 54(2):207-10. PubMed ID: 6586277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.